메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 33, Issue 10, 2015, Pages 1101-1103
Disparities in castration-resistant prostate cancer trials
Author keywords

[No Author keywords available]
Indexed keywords

CANCER SURVIVAL; CASTRATION RESISTANT PROSTATE CANCER; CLINICAL TRIAL (TOPIC); FOOD AND DRUG ADMINISTRATION; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HUMAN; NATIONAL HEALTH ORGANIZATION; NOTE; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); AFRICAN AMERICAN; CAUCASIAN; ETHNOLOGY; MALE; PHASE 3 CLINICAL TRIAL (TOPIC); PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; STATISTICS AND NUMERICAL DATA; UNITED STATES;
EID: 84927515455     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.1751     Document Type: Note
Times cited : (45)
References (17)
  • 1
    • 0010964534 scopus 로고
    • New York, NY, Harper and Row
    • King ML Jr: Strength to Love. New York, NY, Harper and Row, 1963, pp 82-83
    • (1963) Strength to Love. , pp. 82-83
    • King, M.L.1
  • 2
    • 84899484919 scopus 로고    scopus 로고
    • Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
    • Edwards BK, Noone AM, Mariotto AB, et al: Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120:1290-1314, 2013
    • (2013) Cancer , vol.120 , pp. 1290-1314
    • Edwards, B.K.1    Noone, A.M.2    Mariotto, A.B.3
  • 3
    • 0035819936 scopus 로고    scopus 로고
    • Racial and ethnic differences in advanced-stage prostate cancer: The Prostate Cancer Outcomes Study
    • Hoffman RM, Gilliland FD, Eley JW, et al: Racial and ethnic differences in advanced-stage prostate cancer: The Prostate Cancer Outcomes Study. J Natl Cancer Inst 93:388-395, 2001
    • (2001) J Natl Cancer Inst , vol.93 , pp. 388-395
    • Hoffman, R.M.1    Gilliland, F.D.2    Eley, J.W.3
  • 4
    • 77955066199 scopus 로고    scopus 로고
    • Sipuleucel-T immunotherapy for castration-resistant prostate cancer
    • Kantoff PW, Higano CS, Shore ND, et al: Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411-422, 2010
    • (2010) N Engl J Med , vol.363 , pp. 411-422
    • Kantoff, P.W.1    Higano, C.S.2    Shore, N.D.3
  • 5
    • 79957443342 scopus 로고    scopus 로고
    • Abiraterone and increased survival in metastatic prostate cancer
    • De Bono JS, Logothetis CJ, Molina A, et al: Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995-2005, 2011
    • (2011) N Engl J Med , vol.364 , pp. 1995-2005
    • De Bono, J.S.1    Logothetis, C.J.2    Molina, A.3
  • 6
    • 84872078210 scopus 로고    scopus 로고
    • Abiraterone in metastatic prostate cancer without previous chemotherapy
    • Ryan CJ, Smith MR, de Bono JS, et al: Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 368:138-148, 2013
    • (2013) N Engl J Med , vol.368 , pp. 138-148
    • Ryan, C.J.1    Smith, M.R.2    De Bono, J.S.3
  • 7
    • 84866770294 scopus 로고    scopus 로고
    • Increased survival with enzalutamide in prostate cancer after chemotherapy
    • Scher HI, Fizazi L, Saad F, et al: Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367:1187-1197, 2012
    • (2012) N Engl J Med , vol.367 , pp. 1187-1197
    • Scher, H.I.1    Fizazi, L.2    Saad, F.3
  • 8
    • 84908450155 scopus 로고    scopus 로고
    • Enzalutamide in metastatic prostate cancer before chemotherapy
    • Beer TM, Armstrong AJ, Rathkopf DE, et al: Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med 371:424-433, 2014
    • (2014) N Engl J Med , vol.371 , pp. 424-433
    • Beer, T.M.1    Armstrong, A.J.2    Rathkopf, D.E.3
  • 9
    • 77957682309 scopus 로고    scopus 로고
    • Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial
    • de Bono JS, Oudard S, Ozguroglu M, et al: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial. Lancet 376:1147-1154, 2010
    • (2010) Lancet , vol.376 , pp. 1147-1154
    • De Bono, J.S.1    Oudard, S.2    Ozguroglu, M.3
  • 10
    • 84880428467 scopus 로고    scopus 로고
    • Alpha emitter radium-223 and survival in metastatic prostate cancer
    • Parker C, Nilsson S, Heinrich D, et al: Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 369:213-223, 2013
    • (2013) N Engl J Med , vol.369 , pp. 213-223
    • Parker, C.1    Nilsson, S.2    Heinrich, D.3
  • 11
    • 84908512546 scopus 로고    scopus 로고
    • Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013
    • Wissing MD, Kluetz PG, Ning YM, et al: Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013. Cancer 120:3025-3032, 2014
    • (2014) Cancer , vol.120 , pp. 3025-3032
    • Wissing, M.D.1    Kluetz, P.G.2    Ning, Y.M.3
  • 12
    • 84900032336 scopus 로고    scopus 로고
    • Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials
    • Hawk ET, Habermann EB, Ford JG, et al: Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials. Cancer 120:1113-1121, 2014
    • (2014) Cancer , vol.120 , pp. 1113-1121
    • Hawk, E.T.1    Habermann, E.B.2    Ford, J.G.3
  • 13
    • 84882739580 scopus 로고    scopus 로고
    • New developments in the management of prostate cancer
    • Kantoff PW, Mohler JL: New developments in the management of prostate cancer. J Natl Compre Canc Netw 11:653-657, 2013
    • (2013) J Natl Compre Canc Netw , vol.11 , pp. 653-657
    • Kantoff, P.W.1    Mohler, J.L.2
  • 14
    • 33746820665 scopus 로고    scopus 로고
    • The North Carolina-Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes
    • Schroeder JC, Bensen JT, Su LJ, et al: The North Carolina-Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes. Prostate 66:1162-1176, 2006
    • (2006) Prostate , vol.66 , pp. 1162-1176
    • Schroeder, J.C.1    Bensen, J.T.2    Su, L.J.3
  • 15
    • 84886789776 scopus 로고    scopus 로고
    • Project Data Sphere to make cancer clinical trial data publicly available
    • Hede K: Project Data Sphere to make cancer clinical trial data publicly available. J Natl Cancer Inst 105:1159-1160, 2013
    • (2013) J Natl Cancer Inst , vol.105 , pp. 1159-1160
    • Hede, K.1
  • 16
    • 84877889323 scopus 로고    scopus 로고
    • A systematic review of the factors influencing African Americans' participation in cancer clinical trials
    • Rivers D, August EM, Sehovic I, et al: A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35:13-32, 2013
    • (2013) Contemp Clin Trials , vol.35 , pp. 13-32
    • Rivers, D.1    August, E.M.2    Sehovic, I.3
  • 17
    • 84896731433 scopus 로고    scopus 로고
    • Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program
    • Langford AT, Resnicow K, Dimond EP, et al: Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program. Cancer 120:877-884, 2014
    • (2014) Cancer , vol.120 , pp. 877-884
    • Langford, A.T.1    Resnicow, K.2    Dimond, E.P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.